Seize the opportunity, strive for a new high point of cement performance, find the right track, break through the bottleneck period of the pharmaceutical company, the chairman of the board of directors points out the direction for the work in the coming year.
Release time:
2022-02-08
2021 held on February 26 , Jiang Xiaomeng, secretary of the party Committee and chairman of the group company, made a summary speech entitled "seize the opportunity and strive for a new high point in cement performance" in view of the current market situation and existing problems faced by the company. Find the track and break through the bottleneck period of pharmaceutical companies, pointing out direction and requirements for the company's work in 2022 . Jiang Xiaomeng pointed out that in
2021, the company achieved relatively ideal operating results in a complex market environment, which is not only the foundation laid by the company's industrial structure adjustment and capital investment in recent years, but also the result of the joint efforts of management departments at all levels and employees of production enterprises. The general manager's work report comprehensively analyzes and expounds the company's current business situation and future direction of efforts, which is the arrangement made by the management of the group company after close analysis and careful consideration. I hope that the management team of each enterprise will seriously understand and implement it, so as to better complete all the work in the new year. When talking about the work direction of
2022, Jiang Xiaomeng summed it up in two sentences, namely, "seize the opportunity and strive for a new high in cement performance; Find the right track and break through the bottleneck period of pharmaceutical companies". Jiang Xiaomeng said that the Central Economic Work Conference pointed out that the economic work in
2022should "take the lead in stability and seek progress in stability" and "continue to implement a proactive fiscal policy and a prudent monetary policy". The economic work conferences of all provinces have also released relevant positive signals, which shows that the government will take measures to stimulate the economy; as the epidemic situation in major foreign power coal supply countries is relatively under control, energy prices have also entered a downward channel, which will reduce the cost pressure of raw fuel materials for cement enterprises. In recent years, cement enterprises under the peak have continuously increased their investment in equipment and technology upgrading, and cost control is expected to be significantly improved. The superposition of these internal and external factors will bring opportunities to the peak cement plate. Therefore, all cement enterprises should take stock of the situation, seize the favorable opportunity and do a good job in the homework of "cement ", that is, extend the cement industry chain to the upstream and downstream, realize vertical integration, and take aggregate, machine-made sand and solid and hazardous waste treatment as the new profit-making points of cement plate, so as to create better business performance. For the peak medicine sector, Jiang Xiaomeng believes that peak medicine
20has developed over the years, accumulated a number of talents and technologies, cultivated some new products, and its product structure has been continuously adjusted according to market changes. Although the current centralized band procurement has an impact on drug prices, the sales growth of the winning varieties is also conducive to the dilution of costs, which has been reflected in the market sales of peak pharmaceutical olopatadine eye drops. From the perspective of industry development trends, as the global failure rate of new drug research and development is getting higher and higher, and it is becoming more and more difficult to develop new targets, improved new drugs that upgrade existing drugs may be another blue ocean for pharmaceutical companies. At the same time, the continuous improvement of environmental protection requirements make API production resources increasingly scarce, the advantages of the North Carolina API base of Peak Pharmaceuticals will become more and more obvious. Therefore, the new track of peak pharmaceutical industry should be developed to eye drops and ophthalmic drugs, to improved new drugs, and to the integration of raw materials and preparations. Jiang Xiaomeng said that while identifying its own advantages and efforts, it is also necessary to see its own shortcomings. There is still room for improvement in many indicators and labor productivity of Jianfeng cement enterprises, and the research and development speed of Jianfeng Pharmaceutical products is not as fast as expected, which requires management teams at all levels to break away from their inherent thinking and further improve their ability and methods of solving problems in terms of management, communication, coordination and team unity. Through the joint efforts of all employees and doing a good job in accordance with the company's deployment, we will certainly achieve better performance in the new year. (this newspaper reporter)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11